- Abstract
- Core Tip
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (15)
- Timeline of Article Publication Processes (9)
- Authors Evaluation (3)
- Article Quality Tracking (1)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (175) -
Full Article (PDF) (68) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7217)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2020 (publication date) through May 21, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alharthi J, Latchoumanin O, George J, Eslam M. Macrophages in metabolic associated fatty liver disease. World J Gastroenterol 2020; 26(16): 1861-1878 [PMID: 32390698 DOI: 10.3748/wjg.v26.i16.1861] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i16/1861.htm |
| Number | Citing Articles |
| 1 |
Sahil Khanna, Neal S. Parikh, Lisa B. VanWagner. Fatty liver and cerebrovascular disease: plausible association and possible mechanisms. Current Opinion in Lipidology 2022; 33(1): 31 doi: 10.1097/MOL.0000000000000799
|
| 2 |
Anika Niambi Al-Shura. Metabolic Disorders and Shen in Integrative Cardiovascular Chinese Medicine. 2021; : 17 doi: 10.1016/B978-0-12-818922-1.00003-9
|
| 3 |
Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, Gian L. Rapaccini, Antonio Gasbarrini, Antonio Grieco. COVID‐19, adaptative immune response and metabolic‐associated liver disease. Liver International 2021; 41(11): 2560 doi: 10.1111/liv.15061
|
| 4 |
Yu Jung Heo, Sung‐E Choi, Nami Lee, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse model. Journal of Gastroenterology and Hepatology 2021; 36(9): 2592 doi: 10.1111/jgh.15465
|
| 5 |
Shanshan Liu, Jialu Wang, Shujing Wu, Jingya Niu, Ruizhi Zheng, Lizhan Bie, Zhuojun Xin, Shuangyuan Wang, Hong Lin, Zhiyun Zhao, Tiange Wang, Min Xu, Jieli Lu, Yuhong Chen, Yiping Xu, Weiqing Wang, Guang Ning, Yufang Bi, Mian Li, Yu Xu. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis. Metabolism 2021; 120: 154779 doi: 10.1016/j.metabol.2021.154779
|
| 6 |
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling. Metabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
|
| 7 |
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares-da-Silva. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?. Hepatology International 2021; 15(2): 380 doi: 10.1007/s12072-021-10157-y
|
| 8 |
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>. Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
|
| 9 |
Yiyuan Zheng, Dan Fang, Chaoyuan Huang, Lina Zhao, Liming Gan, Youlan Chen, Fengbin Liu. Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.816032
|
| 10 |
Jawaher Alharthi, Mohammed Eslam. Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update. Journal of Clinical and Translational Hepatology 2022; 10(1): 134 doi: 10.14218/JCTH.2021.00248
|
| 11 |
Sherine Ahmed Elsherif, Ahmed Salah Alm. Role of macrophages in liver cirrhosis: fibrogenesis and resolution. Anatomy & Cell Biology 2022; 55(1): 14 doi: 10.5115/acb.21.046
|
| 12 |
Lili Yu, Wei Hong, Shen Lu, Yanrong Li, Yaya Guan, Xiaogang Weng, Zhiwei Feng. The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.780496
|
| 13 |
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 51 doi: 10.1080/17474124.2020.1817740
|